Cargando…

Mammaglobin-A is a target for breast cancer vaccination

We recently completed a phase 1 clinical trial demonstrating the safety of a mammaglobin-A DNA vaccine in patients with metastatic breast cancer. We are currently enrolling patients with early stage breast cancer in a phase 1b clinical trial. The mammaglobin-A DNA vaccine will be administered concur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Samuel W., Goedegebuure, Peter, Gillanders, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801441/ https://www.ncbi.nlm.nih.gov/pubmed/27057470 http://dx.doi.org/10.1080/2162402X.2015.1069940

Ejemplares similares

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells
por: Hassan, Eman M., et al.
Publicado: (2017)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible?
por: DeGregorio, Michael, et al.
Publicado: (2012)

Identification of human tissue cross-presenting dendritic cells: A new target for cancer vaccines
por: Haniffa, Muzlifah, et al.
Publicado: (2013)

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
por: Thakur, Archana, et al.
Publicado: (2015)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

Mammaglobin as a potential molecular target for breast cancer drug delivery
por: Zuo, Lian, et al.
Publicado: (2009)

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013)

Inhibition of RANK signaling as a potential immunotherapy in breast cancer
por: Gómez-Aleza, C, et al.
Publicado: (2021)

In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeting NK cell activation
por: Ferlazzo, Guido
Publicado: (2012)

Discovering cancer immunotherapy targets in vivo
por: Zhou, Penghui, et al.
Publicado: (2014)

Tumor-targeting vaccination instructs graft-vs.-tumor immune responses
por: Manzo, Teresa, et al.
Publicado: (2013)

Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth
por: Dentelli, Patrizia, et al.
Publicado: (2014)

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

Cancer vaccines: shared tumor antigens return to the spotlight
por: Li, Lijin, et al.
Publicado: (2020)

Chemokine-enhanced DNA vaccination in cancer immunotherapy
por: Igoucheva, Olga, et al.
Publicado: (2013)

Personal neoantigen cancer vaccines: The momentum builds
por: Fritsch, Edward F, et al.
Publicado: (2014)

Personalized peptide vaccination for advanced colorectal cancer
por: Sasada, Tetsuro, et al.
Publicado: (2015)

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Predicting the efficacy of cancer vaccines by evaluating T-cell responses
por: van Duikeren, Suzanne, et al.
Publicado: (2013)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Stress-induced metastatic niches in breast cancer
por: Oskarsson, Thordur
Publicado: (2020)

New control of the senescence barrier in breast cancer
por: Costa, Tânia D. F., et al.
Publicado: (2020)

Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study
por: Mikhitarian, Kaidi, et al.
Publicado: (2008)

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy
por: Issa-Nummer, Yasmin, et al.
Publicado: (2014)

ZMYND8 is a primary HIF coactivator that mediates breast cancer progression
por: Chen, Yan, et al.
Publicado: (2018)

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity
por: Chandler, Benjamin C., et al.
Publicado: (2020)

Prostate cancer: Important steps and considerations in the design of therapeutic vaccines
por: McArdle, Stephanie EB, et al.
Publicado: (2014)

Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
por: Walker, Paul R., et al.
Publicado: (2015)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard
por: Hailemichael, Yared, et al.
Publicado: (2013)

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
por: Rossig, Claudia
Publicado: (2012)

COX2 regulation of breast cancer bone metastasis
por: Karavitis, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sj1ddqdtu8qgv70vqua6vjcr0r